IRIS Accounts Production v26.1.0.640 07396287 Board of Directors 1.11.24 31.10.25 31.10.25 false true false false true false 17436 12447 49359 48840 41285 43851 25510 17436 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 07396287 2024-10-31 07396287 2025-10-31 07396287 2024-11-01 2025-10-31 07396287 2023-10-31 07396287 2023-11-01 2024-10-31 07396287 2024-10-31 07396287 ns15:EnglandWales 2024-11-01 2025-10-31 07396287 ns14:PoundSterling 2024-11-01 2025-10-31 07396287 ns10:Director1 2024-11-01 2025-10-31 07396287 ns10:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 07396287 ns10:SmallEntities 2024-11-01 2025-10-31 07396287 ns10:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 07396287 ns10:SmallCompaniesRegimeForDirectorsReport 2024-11-01 2025-10-31 07396287 ns10:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 07396287 ns10:FullAccounts 2024-11-01 2025-10-31 07396287 42 ns10:Director2 2024-10-31 07396287 42 ns10:Director2 2023-10-31 07396287 42 ns10:Director2 2024-11-01 2025-10-31 07396287 42 ns10:Director2 2023-11-01 2024-10-31 07396287 42 ns10:Director2 2025-10-31 07396287 42 ns10:Director2 2024-10-31 07396287 ns10:Director2 2024-11-01 2025-10-31 07396287 ns10:RegisteredOffice 2024-11-01 2025-10-31 07396287 ns5:CurrentFinancialInstruments 2025-10-31 07396287 ns5:CurrentFinancialInstruments 2024-10-31 07396287 ns5:Non-currentFinancialInstruments 2025-10-31 07396287 ns5:Non-currentFinancialInstruments 2024-10-31 07396287 ns5:ShareCapital 2025-10-31 07396287 ns5:ShareCapital 2024-10-31 07396287 ns5:RetainedEarningsAccumulatedLosses 2025-10-31 07396287 ns5:RetainedEarningsAccumulatedLosses 2024-10-31 07396287 ns5:FurnitureFittings 2024-11-01 2025-10-31 07396287 ns5:ComputerEquipment 2024-11-01 2025-10-31 07396287 ns5:FurnitureFittings 2024-10-31 07396287 ns5:ComputerEquipment 2024-10-31 07396287 ns5:FurnitureFittings 2025-10-31 07396287 ns5:ComputerEquipment 2025-10-31 07396287 ns5:FurnitureFittings 2024-10-31 07396287 ns5:ComputerEquipment 2024-10-31 07396287 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-10-31 07396287 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-10-31 07396287 ns5:WithinOneYear 2025-10-31 07396287 ns5:WithinOneYear 2024-10-31 07396287 ns10:Director1 1 2024-10-31 07396287 ns10:Director1 1 2023-10-31 07396287 ns10:Director1 1 2024-11-01 2025-10-31 07396287 ns10:Director1 1 2023-11-01 2024-10-31 07396287 ns10:Director1 1 2025-10-31 07396287 ns10:Director1 1 2024-10-31

REGISTERED NUMBER: 07396287 (England and Wales)

Financial Statements for the Year Ended 31 October 2025

for

Lily Neurology Limited

Lily Neurology Limited (Registered number: 07396287)

Contents of the Financial Statements

for the Year Ended 31 October 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

Lily Neurology Limited

Company Information

for the Year Ended 31 October 2025

| DIRECTORS: | Dr O E M Lily

| Mrs R S Lily

| REGISTERED OFFICE: | 94 Pannal Ash Road

| Harrogate

| North Yorkshire

| HG2 9AJ

| REGISTERED NUMBER: | 07396287 (England and Wales)

| ACCOUNTANTS: | Richard Smedley Limited

| Chartered Accountants & Registered Auditors

| Richmond House

| Lawnswood Business Park

| Redvers Close

| Leeds

| West Yorkshire

| LS16 6QY

Lily Neurology Limited (Registered number: 07396287)

Balance Sheet

31 October 2025

| 31.10.25 | 31.10.24 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 1,954 |  | 2,423 |  |

CURRENT ASSETS

Debtors | 5 | 25,510 |  | 17,619 |  |

Cash at bank | 20,182 |  | 16,800 |  |

45,692 |  | 34,419 |  |

CREDITORS

Amounts falling due within one year | 6 | 35,545 |  | 31,979 |  |

NET CURRENT ASSETS | 10,147 |  | 2,440 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 12,101 |  | 4,863 |  |

CREDITORS

Amounts falling due after more than one year | 7 | - |  | (2,105 | ) |

PROVISIONS FOR LIABILITIES | (489 | ) | (606 | ) |

NET ASSETS | 11,612 |  | 2,152 |  |

CAPITAL AND RESERVES

Called up share capital | 100 |  | 100 |  |

Retained earnings | 11,512 |  | 2,052 |  |

SHAREHOLDERS' FUNDS | 11,612 |  | 2,152 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lily Neurology Limited (Registered number: 07396287)

Balance Sheet - continued

31 October 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 April 2026 and were signed on its behalf by:

Dr O E M Lily - Director

Lily Neurology Limited (Registered number: 07396287)

Notes to the Financial Statements

for the Year Ended 31 October 2025

1. | STATUTORY INFORMATION

| Lily Neurology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover represents fees receivable for medical consultancy provided during the period.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Furniture, fixtures, fittings and equipment |  | - | 15% on reducing balance

| Computer equipment | - | 33% on cost

| Financial instruments

| Basic financial instruments are recognised at amortised cost, derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 2 (2024 - 2 ) .

Lily Neurology Limited (Registered number: 07396287)

Notes to the Financial Statements - continued

for the Year Ended 31 October 2025

4. | TANGIBLE FIXED ASSETS

| Furniture, |

| fixtures, |

| fittings |

| and |  | Computer |

| equipment |  | equipment |  | Totals

£ | £ | £ |

| COST

| At 1 November 2024 | 3,995 |  | 4,265 |  | 8,260 |  |

| Additions | 205 |  | - |  | 205 |  |

| At 31 October 2025 | 4,200 |  | 4,265 |  | 8,465 |  |

| DEPRECIATION

| At 1 November 2024 | 1,901 |  | 3,936 |  | 5,837 |  |

| Charge for year | 345 |  | 329 |  | 674 |  |

| At 31 October 2025 | 2,246 |  | 4,265 |  | 6,511 |  |

| NET BOOK VALUE

| At 31 October 2025 | 1,954 |  | - |  | 1,954 |  |

| At 31 October 2024 | 2,094 |  | 329 |  | 2,423 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.10.25 |  | 31.10.24

£ | £ |

| Other debtors | 25,510 |  | 17,619 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.10.25 |  | 31.10.24

£ | £ |

| Bank loans and overdrafts | 2,105 |  | 2,051 |  |

| Taxation and social security | 30,891 |  | 28,282 |  |

| Other creditors | 2,549 |  | 1,646 |  |

35,545 |  | 31,979 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 31.10.25 |  | 31.10.24

£ | £ |

| Bank loans | - |  | 2,105 |  |

Lily Neurology Limited (Registered number: 07396287)

Notes to the Financial Statements - continued

for the Year Ended 31 October 2025

8. | LEASING AGREEMENTS

| Minimum lease payments under non-cancellable operating leases fall due as follows:

| 31.10.25 |  | 31.10.24

£ | £ |

| Within one year | 2,923 |  | 2,923 |  |

9. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to directors subsisted during the years ended 31 October 2025 and 31 October 2024:

| 31.10.25 |  | 31.10.24

£ | £ |

| Dr O E M Lily and Mrs R S Lily

| Balance outstanding at start of year | 17,436 |  | 12,447 |  |

| Amounts advanced | 49,359 |  | 48,840 |  |

| Amounts repaid | (41,285 | ) | (43,851 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 25,510 |  | 17,436 |  |